Oncology Research and Treatment

2.5k papers and 21.6k indexed citations i.

About

The 2.5k papers published in Oncology Research and Treatment in the last decades have received a total of 21.6k indexed citations. Papers published in Oncology Research and Treatment usually cover Oncology (1.1k papers), Pulmonary and Respiratory Medicine (788 papers) and Surgery (448 papers) specifically the topics of Cancer Treatment and Pharmacology (196 papers), Lung Cancer Treatments and Mutations (166 papers) and Gastric Cancer Management and Outcomes (152 papers). The most active scholars publishing in Oncology Research and Treatment are Lutz Edler, Carsten Bokemeyer, Ralf‐Dieter Hofheinz, W. Queißer and E. Dühmke.

In The Last Decade

Fields of papers published in Oncology Research and Treatment

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Oncology Research and Treatment. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Oncology Research and Treatment

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Oncology Research and Treatment. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Oncology Research and Treatment with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025